Article info

Download PDFPDF

Ceftolozane–tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study
Free

Authors

  • Edward Raby Infectious Diseases Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia Internal Medicine, University of Western Australia Faculty of Medicine Dentistry and Health Sciences, Crawley, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Saiyuri Naicker University Of Queensland Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia Centre for Translational Anti-infective Pharmacodynamics, Pharmacy Australia Centre of Excellence, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Fekade Bruck Sime University Of Queensland Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia Centre for Translational Anti-infective Pharmacodynamics, Pharmacy Australia Centre of Excellence, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Laurens Manning Infectious Diseases Department, Fiona Stanley Hospital, Murdoch, Western Australia, Australia Internal Medicine, University of Western Australia Faculty of Medicine Dentistry and Health Sciences, Crawley, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Steven C Wallis University Of Queensland Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia PubMed articlesGoogle scholar articles
  • Saurabh Pandey University Of Queensland Centre for Clinical Research, University of Queensland, Herston, Queensland, Australia PubMed articlesGoogle scholar articles
  • Jason A Roberts Centre for Translational Anti-infective Pharmacodynamics, Pharmacy Australia Centre of Excellence, Brisbane, Queensland, Australia Pharmacy Department, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Edward Raby, Infectious Diseases, Fiona Stanley Hospital, Murdoch WA 6150, Australia; edward.raby{at}health.wa.gov.au
View Full Text

Citation

Raby E, Naicker S, Sime FB, et al
Ceftolozane–tazobactam in an elastomeric infusion device for ambulatory care: an in vitro stability study

Publication history

  • Received September 16, 2019
  • Revised November 22, 2019
  • Accepted December 4, 2019
  • First published December 16, 2019.
Online issue publication 
March 26, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.